October 24th, 2025
This conference has already taken place.
Description
We will update the audience on new developments on the perioperative treatment of lung cancer, on the treatment of patients with metastatic disease with actionable mutations, on the treatment of patients with metastatic disease who lack actionable mutations, on novel radiotherapeutic approaches and updates on the surgical management of patients with lung cancer (especially following induction chemoimmunotherapy).
For pricing information, see pricing tab below.
Dates and Times
Start: 10/24/2025 11:00 AM
End: 10/24/2025 4:35 PM
Objectives
1. Review the Latest Advances in Early-Stage NSCLC Management
2. Use a Multidisciplinary Team approach in managing Complex Lung Cancer Cases
3. Review Therapeutic Approaches for EGFR-Positive NSCLC
4. Review the Role of Liquid Biopsies in Lung Cancer Diagnosis and Monitoring
Pricing
| Tier | Price |
|---|---|
| Free | $0.00 |
| Physician | $0.00 |
| Physician Assistant | $0.00 |
| Advanced Practice Provider | $0.00 |
| Nurse/Nurse Practitioner | $0.00 |
| Allied Medical Professional | $0.00 |
| Other | $0.00 |
Location
The Grand Event Center
820 Goodale Blvd.
Columbus , OH 43212
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.